MRNA Wins FDA Panel Backing
Moderna's mRNA flu vaccine benefits outweigh the risks in adults aged 65 and above
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Moderna's mRNA flu vaccine benefits outweigh the risks in adults aged 65 and above
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.